There is accumulating evidence that SAA is a reliable biomarker for several autoinflammatory and rheumatic diseases, and that it is involved in the pathophysiology of rheumatoid arthritis (RA), familial Mediterranean fever (FMF), sarcoidosis, and vasculitis. This evidence concerns the gene SAA1 and rheumatic disorder.